Indeed, check out GSK which is also funding Ellume.
Possible connection?
Should Anteo be able to gain access to GSK and Qiagen due to an increased partnership with Ellume, prodiving
much needed additional manufacturing capabilities Internationally?
Our raw material supply deal with Ellume expires this year and possibly be replaced by a proper partner deal between two
assay producers, sharing their International partners?
Highly likely scenario and a win win for both, securing our technology for Ellume in their continued expansion of US business.
They have to give us something in return to allow them to keep using our core technology for their success.
all IMO
Ann: Up to $1.4m in Qld Grant for COVID-19 test development, page-85
-
- There are more pages in this discussion • 58 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add ADO (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
2.2¢ |
Change
0.001(4.76%) |
Mkt cap ! $54.77M | |||
| Open | High | Low | Value | Volume |
| 2.0¢ | 2.2¢ | 2.0¢ | $12.70K | 583.2K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 1191253 | 2.1¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 2.2¢ | 520012 | 3 |
View Market Depth
| Last trade - 16.10pm 01/10/2024 (20 minute delay) ? |
| ADO (ASX) Chart |